Is prophylactic cranial irradiation necessary in individuals suffering from surgically resected pT1-2N0M0 small cell lung cancer?
Hongyang LuZhiming JiangChenghui LiPublished in: Irish journal of medical science (2018)
Adjuvant chemotherapeutics and prophylactic cranial irradiation (PCI) are both recommended in the National Comprehensive Cancer Network (NCCN) guidelines for treating individuals suffering from surgically resected pT1-2N0M0 small cell lung cancer (SCLC). Whether adjuvant chemotherapy combined with PCI is superior to adjuvant chemotherapy alone in these patients is largely unknown. PCI may therefore be with uncertain effects in surgically resected pT1-2N0M0 SCLC.
Keyphrases
- small cell lung cancer
- prognostic factors
- percutaneous coronary intervention
- coronary artery disease
- acute myocardial infarction
- acute coronary syndrome
- lymph node
- antiplatelet therapy
- end stage renal disease
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- atrial fibrillation
- chronic kidney disease
- ejection fraction
- newly diagnosed
- coronary artery bypass grafting
- brain metastases
- papillary thyroid
- radiation induced
- heart failure
- quality improvement
- patient reported outcomes
- radiation therapy
- patient reported